A Comparative Evaluation of a MPS Dressing and a CMC Dressing on Subjects With Lower Extremity Venous Ulcers

NATerminatedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

September 30, 2019

Primary Completion Date

December 21, 2022

Study Completion Date

December 21, 2022

Conditions
Venous Leg Ulcer
Interventions
DEVICE

Marine polysaccharide dressing

The MPS-Ag dressing used in this study has a unique gelling action which helps to remove dead, damaged, and infected tissues from the wound by trapping and removing them later at dressing changes. It is designed to provide intimate contact with the wound for gentle healing. It also contains ionic silver.

DEVICE

Carboxymethylcellulose dressing

The CMC-Ag dressing used in this study incorporates two technologies to help eliminate the key barriers to healing that are exudate, infection, and bioburden. It can be used on chronic and acute wounds that are infected or at risk of infection with varying exudate levels.

Trial Locations (5)

27157

Wake Forest Baptist Health, Winston-Salem

48602

Covenant Hospital, Saginaw

93662

Central Valley Vein and Wound Center, Selma

93720

Valley Vascular Surgery Associates, Fresno

02118

Boston Medical Center, Boston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Medline Industries

INDUSTRY

NCT03903692 - A Comparative Evaluation of a MPS Dressing and a CMC Dressing on Subjects With Lower Extremity Venous Ulcers | Biotech Hunter | Biotech Hunter